About Endotronix
Endotronix is a company based in East Peoria (United States) founded in 2007 was acquired by Edwards Lifesciences in July 2024. Endotronix has raised $154.77 million across 12 funding rounds from investors including SVB, Edwards Lifesciences and Life Sciences Partners. The company has 104 employees as of December 31, 2022. Endotronix operates in a competitive market with competitors including Ekso Bionics, Edwards Lifesciences, CoachCare, BioIntelliSense and Oxehealth, among others.
- Headquarter East Peoria, United States
- Employees 104 as on 31 Dec, 2022
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Endotronix, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$154.77 M (USD)
in 12 rounds
-
Latest Funding Round
$69.28 M (USD), Series D
Oct 01, 2019
-
Investors
SVB
& 11 more
-
Employee Count
104
as on Dec 31, 2022
-
Acquired by
Edwards Lifesciences
(Jul 01, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Endotronix
Unlock access to complete
Unlock access to complete
Funding Insights of Endotronix
Endotronix has successfully raised a total of $154.77M across 12 strategic funding rounds. The most recent funding activity was a Series D round of $69.28 million completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Endotronix
Endotronix has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, Edwards Lifesciences and Life Sciences Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments in life sciences businesses are managed.
|
Locked | Locked | Locked | |
|
A healthcare-focused investment firm supporting innovative company growth.
|
Locked | Locked | Locked | |
|
Investment in emerging and growth-stage MedTech companies is facilitated.
|
Locked | Locked | Locked |
Investor details for Endotronix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Endotronix
Investment portfolio details for Endotronix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Endotronix
Detailed financials for Endotronix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Endotronix Comparisons
Peer comparison for Endotronix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Endotronix
Endotronix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ekso Bionics, Edwards Lifesciences, CoachCare, BioIntelliSense and Oxehealth, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Exoskeletons for medical rehabilitation and industrial productivity are provided.
|
|
| Locked | Locked | Locked |
Medical devices for structural heart disease are developed and provided.
|
|
| Locked | Locked | Locked |
Remote monitoring platform for tracking patient activity
|
|
| Locked | Locked | Locked |
Vital signs are monitored via a single-use patch and platform.
|
|
| Locked | Locked | Locked |
Contactless patient monitoring is provided for mental health facilities.
|
Detailed competitors of Endotronix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Endotronix
Complete news archive for Endotronix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Endotronix
Endotronix was founded in 2007 and raised its 1st funding round 1 year after it was founded.
Endotronix is headquartered in East Peoria, United States. It is registered at East Peoria, Illinois, United States.
Endotronix is a funded company, having raised a total of $154.77M across 12 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Endotronix is 104.
Endotronix was founded in 2007 in East Peoria, United States, within the medical device sector focused on cardiology. Wireless and implantable pressure sensors are developed to measure cardiac function parameters. A care management solution is provided, enabling pulmonary artery pressure data to be captured via mobile devices and securely transmitted to clinical care teams for analysis and personalized patient oversight.
Endotronix's top competitors include Ekso Bionics, Oxehealth and BioIntelliSense.
Endotronix has 12 investors. Key investors include SVB, Edwards Lifesciences, Life Sciences Partners, OSF HealthCare, and Aperture Venture Partners.